Back to Search
DAMIANO RONDELLI, M.D.
M.D.
Hematology & Oncology Physician
NPI: 1528198884IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
CMS Specialties
PrimaryHEMATOLOGY/ONCOLOGY
Education
OTHER
Class of 1990
Research & Publications (20)
Allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning in intermediate- or high-risk patients with myelofibrosis with myeloid metaplasia.
PMID 15671439·Blood·2005
8-other
Reliability of a pretransplant i.v. BU test dose performed 2 weeks before myeloablative FluBu conditioning regimen.
PMID 19543331·Bone Marrow Transplant·2010
4-observational
Selective apoptosis of monocytes and monocyte-derived DCs induced by bortezomib (Velcade).
PMID 18806836·Bone Marrow Transplant·2009
8-other
Increased donor CD86+CD14+ cells in the bone marrow and peripheral blood of patients with chronic graft-versus-host disease.
PMID 18580477·Transplantation·2008
8-other
Pulmonary extramedullary hematopoiesis in patients with myelofibrosis undergoing allogeneic stem cell transplantation.
PMID 18641018·Haematologica·2008
8-other
Cord blood nucleated cells induce delayed T cell alloreactivity.
PMID 18640570·Biol Blood Marrow Transplant·2008
8-other
Fludarabine/i.v. BU conditioning regimen: myeloablative, reduced intensity or both?
PMID 18264144·Bone Marrow Transplant·2008
3-trial
Effects of extensive splenomegaly in patients with myelofibrosis undergoing a reduced intensity allogeneic stem cell transplantation.
PMID 18324970·Br J Haematol·2008
4-observational
Allogeneic hematopoietic stem cell transplantation for myelofibrosis.
PMID 18827262·Haematologica·2008
8-other
Enhancement of T cell activation by immobilized hu5C8 (anti-CD40L) monoclonal antibody.
PMID 18081708·Eur J Haematol·2008
8-other
Extranodal natural killer/t-cell lymphoma, nasal type, in a patient with a constitutional 11q terminal deletion disorder.
PMID 17476097·Acta Haematol·2007
5-case
Higher numbers of blood CD14+ cells before starting conditioning regimen correlate with greater risk of acute graft-versus-host disease in allogeneic stem cell transplantation from related donors.
PMID 17241928·Biol Blood Marrow Transplant·2007
8-other
Biology and treatment of primary myelofibrosis.
PMID 18024650·Hematology Am Soc Hematol Educ Program·2007
6-review
Philadelphia chromosome-negative myeloproliferative disorders: biology and treatment.
PMID 17222772·Biol Blood Marrow Transplant·2007
6-review
Comparable kinetics of myeloablation between fludarabine/full-dose busulfan and fludarabine/melphalan conditioning regimens in allogeneic peripheral blood stem cell transplantation.
PMID 16980995·Bone Marrow Transplant·2006
3-trial
The use of blood conservation methods in addition to erythropoietin allows myeloablative allogeneic stem cell transplantation without the use of blood products.
PMID 16314850·Bone Marrow Transplant·2006
5-case
Allogeneic T cells induce rapid CD34+ cell differentiation into CD11c+CD86+ cells with direct and indirect antigen-presenting function.
PMID 16478883·Blood·2006
7-preclinical
Prolonged responses after autologous stem cell transplantation in African-American patients with multiple myeloma.
PMID 16699527·Bone Marrow Transplant·2006
4-observational
Liver biopsy findings following donor lymphocyte infusion.
PMID 16048403·Arch Pathol Lab Med·2005
8-other
Multipotent mesenchymal stem cells with immunosuppressive activity can be easily isolated from dental pulp.
PMID 16210973·Transplantation·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1740 W TAYLOR ST, DEPT 3460
CHICAGO, IL 60612 - Phone
- (312) 704-2885
Quick Facts
- NPI
- 1528198884
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 36
- Publications
- 20
Are you this provider?
Claim Your Profile